Background: Zika virus has been responsible for recent outbreaks in the western hemisphere with known neurological complications such as microcephaly. This complication has not been previously documented in continental Africa.
Introduction
Zika virus (ZIKV) infection is transmitted by Aedes mosquitoes and other non-vector-borne pathways (sexual, transfusion, maternal-foetal). Clinically, most infections are asymptomatic or produce mild disease with non-specific symptoms such as fever, headache, arthralgia, conjunctivitis and maculopapular rash. 1 This virus was primarily isolated from a febrile sentinel rhesus monkey (from a yellow fever study) in Zika forest in Uganda. 1 In the following decades the virus was detected and isolated from mosquitoes and in human samples in Africa and Asia. There are two main lineages of ZIKV, the African (represented by the first isolate, the strain MR766) and the Asian lineage. 2 ZIKV was considered a relatively benign mosquito-borne flavivirus until an epidemic in Micronesia (Yap Island) in 2007 and then in French Polynesia in 2013-2014 started a turnover, with the expansion of its epidemic potential, virulence and geographic range, associated with strains belonging to the Asian lineage. 2 Since 2015, there was a large outbreak of ZIKV in the Americas, attaining global attention with its huge epidemiological impact in Brazil, where it was probably introduced in
2013.
1,2 Several neurological complications have been associated with ZIKV infection, including Guillain-Barré syndrome and congenital Zika syndrome in vertically transmitted infections. ZIKV infection during pregnancy can cause microcephaly and other severe foetal brain abnormalities such as intracranial calcifications and eye lesions. 2, 3 According to the latest US Zika Pregnancy Registry report, among all pregnancies with laboratory evidence of possible ZIKV infection, the incidence of birth defects in foetuses or infants was 5%, almost all (89%) related to brain abnormalities and/or microcephaly. 4 In another recent report from the Americas' French territories, which included only symptomatic pregnant women with ZIKV infection, the incidence in foetuses and infants of overall birth defects and microcephaly was 7% and 5.8%, respectively. 5 Higher incidences of birth defects (8% and 12.7%) have also been detected when ZIKV infection occurs during the first trimester of pregnancy. 2, 4, 5 In Africa, recent cases of mosquito-borne ZIKV transmission have been reported in Cape Verde, Guinea-Bissau and Angola. 6, 7 A ZIKV strain was identified in both Cape Verde (Asian lineage) and Guinea-Bissau (African lineage). 7 In Angola, the virus strain has not yet been identified and recently an increase in the incidence of congenital microcephaly has been reported, mostly in the southern Luanda region. 8 This increase may be important because of the potential spread of ZIKV from Angola to other continental African countries. 7 Here we report on an infant with prenatal findings of severe foetal growth restriction and brain abnormalities, including ventriculomegaly and cerebral calcifications, with a confirmed diagnosis of congenital ZIKV infection imported from Angola.
Results
A 33-year-old pregnant woman, a resident of Luanda, Angola (an area with mosquito borne ZIKV transmission), with an obstetric history of neonatal death due to placental abruption (in 2016), travelled to Portugal and Lubango (Angola) in 2017, during the first trimester of pregnancy. Her husband was also a resident of Luanda and denied any recent travel. She reported no symptoms of febrile illness, rash, arthralgia or conjunctivitis or any other symptoms compatible with ZIKV infection during pregnancy. Prenatal care was administered in Angola between 18 and 32 weeks, no vaccination against flaviviruses was reported, no malaria prophylaxis nor any medication other than iron and folic acid supplementation. The first foetal movements were noted at 4 months and foetal ultrasounds were performed in Angola at 18, 22 and 27 weeks, revealing foetal symmetric growth restriction but no morphologic abnormalities.
She travelled to Portugal at 32 weeks and at 37 weeks she went to the emergency room with suspected premature rupture of membranes. Foetal ultrasound revealed severe intra-uterine growth restriction (percentile 0.2), severe ventriculomegaly with cerebral calcifications and oligohydramnios (amniotic fluid index 1.8 cm). Laboratory evaluation for toxoplasmosis, syphilis, varicella zoster, parvovirus B19, rubella, cytomegalovirus and herpes infection was negative, as well as for hepatitis C virus. A provisional diagnosis of ZIKV infection during pregnancy was made, postponing further studies until after birth due to severe foetal growth restriction. An elective caesarean section was performed at 38 weeks and a baby girl was born with an Apgar score of 9/10, Other than the growth restriction and microcephaly with disproportionate rough facies, no other signs of external anomalies were apparent, including joint contractures, skin lesions or external ocular abnormalities. The early neonatal period was uneventful, with exclusive breastfeeding and normal neurologic examination upon hospital discharge on the third day of life. A cerebral ultrasound performed on the second day revealed hypoplasia of the corpus callosum, moderate ventriculomegaly of the occipital horns of the lateral ventricles, intraventricular septations and small parenchymal cysts and microcalcifications located in the frontal, temporal and parietal lobes. Placenta, blood and urine samples were collected from both the mother and newborn and sent to the National Institute of Health for Zika molecular and serologic tests (see below).
At a paediatric neurology follow-up consultation at age 1 month, the infant showed no feeding difficulties, with adequate postnatal growth on exclusive breastfeeding (weight 3160 g; 7th percentile) but disproportionate microcephaly (32.6 cm; <1st percentile; Z score −2.7). There was no seizure activity or apparent signs compatible with increased intracranial pressure. At the neurologic examination, slightly increased tone and deep tendon reflexes were present and a newborn hearing test with otoacoustic emissions showed no evidence of hearing impairment. Cerebral magnetic resonance at 2 months of age confirmed the previous ultrasound findings showing reduced brain volume with simplified gyral pattern, subcortical white matter lesions with frontotemporal punctiform calcifications, supratentorial ventriculomegaly, particularly of the occipital horns of the lateral ventricles, with hypogenesia of the corpus callosum and hypoplasia of the brainstem (Figure 1) .
At the National Institute of Health, the mother's sera samples were tested by immunofluorescent assay (IFA; immunoglobulin G [IgG] and IgM) for ZIKV. Serological results were negative for IgM (titre<16) and positive for IgG (titre=256). IFA was also used to test for the presence of Igs specific to other flaviviruses, such as dengue (DENV), yellow fever (YFV), tickborne encephalitis (TBEV) and West Nile virus (WNV). All assay results were negative for IgM and presented cross-reaction signals for IgG. Significant results were obtained for DENV IgG (titre=256), indicating a probable previous DENV infection. For all remaining flaviviruses (YFV, TBEV and WNV) the IgG titre was 128 (cut-off values are ≥16 for IgM and ≥32 for IgG). Newborn serological results were identical.
Nucleic acids from samples from the mother and the newborn were extracted from 400 µl blood samples (collected in ethylenediaminetetraacetic acid (EDTA) tubes) and 900 μl urine samples using the NucliSens easyMAG platform (BioMérieux, Marcy-l'Étoile, France). The presence of ZIKV ribonucleic acid Figure 2 Phylogenetic analysis of ZIKV sequences using partial NS5 sequence region. The maximum likelihood phylogenetic tree was inferred based on 22 ZIKV partial NS5 nucleotide sequences (193 bp) by using MEGA version 7 software. Distance matrices were calculated using a Kimura twoparameter model with a gamma-distributed (G) rate among sites. Bootstrap values obtained from 1000 replicate trees are shown for key nodes (>60%). The scale is shown at the bottom as substitutions per site. GenBank accession number, place and year of isolation are indicated. The ZIKV sequence related to this work is highlighted in a box. Clusters with sequences belonging to the Asian and African lineages are indicated on the left.
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(RNA) was checked by qualitative real-time reverse transcription polymerase chain reaction (RT-PCR) 9 and one-step conventional RT-PCR using Zika-specific primers targeting the non-structural protein 5 (NS5) gene. 10 RT-PCR was negative in all samples except for the newborn urine sample collected on day 1 after birth. The nested PCR fragment (NS5, 193 bp) was sequenced bidirectionally, assembled using BioEdit software (version 7.0.5.3; Ibis Therapeutics, Carlsbad, CA, USA) and submitted to the GenBank database (accession number MG742364). Similarity searches were made within the GenBank data set using the basic local alignment search tool (BLAST) BLASTN algorithm.
11 Maximum likelihood analysis was performed with a Kimura two-parameter model with a gamma-distributed (G) rate among sites (the determined best fit model) using Molecular Evolutionary Genetics Analysis (MEGA) software (version 7). 12 The robustness of the nodes was tested by 1000 bootstrap replications (Figure 2 ).
Discussion
Although ZIKV was discovered in Uganda in 1947, the earliest cases of microcephaly due to congenital ZIKV infection in Africa were only reported in relation to the large outbreak that occurred in the Cape Verde Islands between October 2015 and May 2016 (Asian lineage). 13 The occurrence of a few more cases was suspected in Guinea-Bissau around April 2016, but confirmatory studies lagged. 1, 14 No other cases have so far been confirmed in African countries. As of November 2017, Angola (along with Guinea-Bissau) was identified as a World Health Organization (WHO) category 1 country (meaning 'area with new introduction or re-introduction with ongoing transmission'), 2 but no confirmed cases of microcephaly due to congenital ZIKV infection of Asian or African lineage have been reported. 7 According to the Centers for Disease Control and Prevention recent update on the diagnosis, evaluation and management of possible congenital ZIKV infection, detection of ZIKV nucleic acid in an infant's body fluid (serum or urine) confirms congenital ZIKV infection. 15 In this case, congenital ZIKV infection was established by the detection of ZIKV RNA (RT-PCR) in the urine of the newborn collected on the first day of life. The samples from the mother and newborn were not analysed in the laboratory in parallel with any other suspected ZIKV clinical samples and the positive control used was ZIKV strain MR 766 (African lineage), ruling out any possibility of PCR contamination. Additionally, the obtained sequence (GenBank accession MG742364) is different from any other previously detected ZIKV Asian strains (mainly of Brazilian origin).
The abnormalities identified in this infant (microcephaly, intra-uterine growth restriction, central nervous system malformations) are similar to other published cases, as are the findings from cerebral ultrasounds and magnetic resonance tests (calcifications, absent corpus callosum, ventriculomegaly). 2, 16 The timing of the infection is difficult to determine, as the mother was asymptomatic during pregnancy. The facts that ZIKV IgM antibodies (described to persist for at least 12 weeks 2 ) were negative in both the mother and the newborn and that microcephaly and central nervous system malformations are more likely to develop when the infection occurs in the first trimester 2, 4, 5 suggest that the infection occurred sometime during the first trimester or beginning of the second trimester, when the mother was in Angola.
Conclusions
To our knowledge this is the first report that shows circulation of the Asian lineage in Angola. This is the first congenital Zika syndrome confirmed on mainland Africa and the first detected in Portugal.
